MC4R and hyperinsulinemic hypoglycemia, familial, 4: With a prevalence of ~1/340, Melanocortin 4 receptor deficiency can no longer be considered a “rare disease”, the definition of which, in the UK, is a prevalence of <1/2000 and, in the US, is <200,000 affected patients nationally.